Vasopressin V2 receptor antagonists for the syndrome of inappropriate antidiuretic hormone secretion
International Urology and Nephrology · 2023
DOI: 10.1007/s11255-023-03643-9 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Urology and Nephrology, 2023. Verfasst von Masayuki Tanemoto. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, International University of Health and Welfare School of Medicine, 13-1 Higashi-Kaigan-cho, …. Hauptthemen laut MEDLINE: Antidiuretic Hormone Receptor Antagonists, Hyponatremia, Inappropriate ADH Syndrome. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, International University of Health and Welfare School of Medicine, 13-1 Higashi-Kaigan-cho, Atami, Shizuoka, 413-0012, Japan. mtanemoto-tky@umin.ac.jp.
ORCID-Profile: Masayuki Tanemoto
Zitieren
APA
Tanemoto, M. (2023). Vasopressin V2 receptor antagonists for the syndrome of inappropriate antidiuretic hormone secretion. International Urology and Nephrology. https://doi.org/10.1007/s11255-023-03643-9
Vancouver
Tanemoto M. Vasopressin V2 receptor antagonists for the syndrome of inappropriate antidiuretic hormone secretion. International Urology and Nephrology. 2023. doi:10.1007/s11255-023-03643-9
BibTeX
@article{Tanemoto2023,
author = {Tanemoto, Masayuki},
title = {Vasopressin V2 receptor antagonists for the syndrome of inappropriate antidiuretic hormone secretion},
journal = {International Urology and Nephrology},
year = {2023},
doi = {10.1007/s11255-023-03643-9}
}
EUVIMED